Cancer Talk Blog

Study Supports Evidence that Rab Disruption May Be Effective Strategy for Treating Multiple Myeloma

Roswell Park Cancer Institute (RPCI) researchers are investigating agents that target and disrupt the trafficking of monoclonal antibodies in multiple myeloma, a cancer of the bone marrow. The results will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.

Wednesday, April 20, 2016 - 08:00 am

News

Multivitamin Use Protects Against Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients

Researchers at Roswell Park Cancer Institute (RPCI), in collaboration with investigators from the cooperative group SWOG, have found that use of multivitamins prior to diagnosis may reduce the risk of neuropathy in breast cancer patients treated with the class of drugs known as taxanes.

Tuesday, April 19, 2016 - 08:00 am

News

Roswell Park Comprehensive Cancer Center Acquires Southtowns Hematology/Oncology Practice

Roswell Park Comprehensive Cancer Center has acquired the Southtowns hematology/oncology practice of Isosceles Garbes, MD, increasing convenience and access to advanced oncology services for patients. Roswell Park Hematology Oncology Southtowns is the new name of the practice, which will continue to operate out of 3612 Seneca St. in West Seneca, N.Y., as a Roswell Park community cancer practice.

Tuesday, April 19, 2016 - 08:00 am

News

Combination Therapy Incorporating 3 New Agents Shows Promise As Treatment for Aggressive Lymphoma

New research from Roswell Park Cancer Institute (RPCI) shows that promising cancer drugs used in combination can have significant therapeutic impact on a particularly aggressive subtype of diffuse large B-cell lymphoma (DH-DLBCL) in preclinical studies.

Tuesday, April 19, 2016 - 08:00 am

News

Newly Identified Genetic Markers May Help Guide Treatment Selection in Breast Cancer

Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute (RPCI), in collaboration with the cooperative research group SWOG and St. Jude Children’s Research Hospital.

Monday, April 18, 2016 - 08:00 am

News

Scientists Identify Compounds that May Enhance Antitumor Activity of Vitamin D

Roswell Park Cancer Institute research on the most potent form of vitamin D, commonly called calcitriol, offers new insights into approaches that may enhance the antitumor activity of this much-studied human hormone.

Sunday, April 17, 2016 - 08:00 am

News

Building a Better Robotic Operating Room: Researchers Say Design, Communication Issues Could Impact Outcomes

As robot-assisted surgery changes the traditional interrelationships of surgical teams with the technology around them in the operating room, new opportunities arise for understanding and optimizing operating-room processes.

Saturday, April 16, 2016 - 08:00 am

News

How Can Lay Health Advisor Programs Be Designed for Maximum Impact?

Lay health advisors who share similar social, economic, cultural and linguistic backgrounds and values with the medically underserved groups they interact with have been shown to reduce health disparities.

Thursday, April 14, 2016 - 08:00 am

Article

Sculpting a Legacy

For nearly four years, a statue bearing the likeness of a beloved Roswell Park volunteer has welcomed visitors to our Kaminski Park and Gardens, located outside the main hospital. Monty, Roswell Park’s first-ever therapy dog, serves as a reminder of the compassionate power of animals, now memorialized in the form of a custom statue.

Wednesday, April 13, 2016 - 02:04 pm

Cancer Support